Bigul

Medico Remedies Ltd - 540937 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Harshit Haresh Mehta & Rishit Mehta
10-01-2024
Bigul

Medico Remedies Ltd - 540937 - Disclosure Under Regulation 29(1) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

In terms of Reg 29(1) of SAST Regulations, 2011, we hereby enclose disclosures submitted by Mr. Harshit Mehta and Mr. Rishit Mehta with regards to acquisition of equity shares of the Company by way of off market inter-se transfer pursuant to executed gift deed.
10-01-2024
Bigul

Medico Remedies Ltd - 540937 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Harshit Mehta & Rishit Mehta
10-01-2024
Bigul

Medico Remedies Ltd - 540937 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Haresh Kapurlal Mehta
10-01-2024
Bigul

Medico Remedies Ltd - 540937 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Harshit Haresh Mehta & Rishit Mehta
10-01-2024
Bigul

Medico Remedies Ltd - 540937 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Harshit Harsh Mehta & Rishit Mehta
29-12-2023
Bigul

Medico Remedies Ltd - 540937 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Harshit Haresh Mehta & Rishit Mehta
29-12-2023
Bigul

Medico Remedies Ltd - 540937 - Disclosure Of Inter-Se Transfer Of Shares Among The Promoter And Promoter Group Pursuant To Regulation 10(5) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

Disclosure of Inter-se transfer of shares among Promoters and Promoter Group pursuant to Regulation 10(5) of SEBI (SAST) Regulations, 2011
28-12-2023
Bigul

Medico Remedies Ltd - 540937 - Closure of Trading Window

The Trading window for dealing in equity shares of the Company will be closed for all Insiders, Designated Persons and their immediate relatives from 1st January, 2024 up to the expiry of 48 hours post the date of declaration of the Unaudited Financial Results for the quarter ended 31st December, 2023.
28-12-2023
Bigul

Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Newspaper Publication

In Compliance with Regulation 47 of SEBI (LODR) Regulations, 2015, please find attached newspaper advertisements for publication of announcement of unaudited financial results for the quarter and half year ended 30th September, 2023.
11-11-2023
Next Page
Close

Let's Open Free Demat Account